PRESENTATION

Q3 2021 — Presentation

Q3 2021PDF · 22 pages626 KB
v
v	
v
TransUnion Third Quarter 2021 Earnings
Chris Cartwright, President and CEO
Todd Cello, CFO
October 26, 2021

-- 1 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	2
Forward-Looking Statements
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the
current beliefs and expectations of TransUnion’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those
described in the forward-looking statements. Factors that could cause TransUnion’s actual results to differ materially from those described in the forward-looking
statements include: the effects of the COVID-19 pandemic and the timing of the recovery from the COVID-19 pandemic, failure to realize the synergies and other benefits
expected from the proposed acquisitions of Neustar and Sontiq; delays in closing the proposed acquisitions; the possibility that the proposed acquisitions, including the
integration of Neustar and Sontiq, may be more costly to complete than anticipated; business disruption related to the proposed acquisitions; risks related to the distraction
of management from ongoing business operations and other opportunities due to the proposed acquisitions; the possibility that the expected benefits of the proposed
Healthcare divestiture will not be realized, or will not be realized within the expected time period; failure to obtain governmental approvals of the proposed Healthcare
divestiture in the expected time period, or at all; the impact of the proposed Healthcare divestiture on TransUnion’s businesses and the risk that consummating the
proposed Healthcare divestiture may be more difficult, time-consuming or costly than expected; the possibility that the proposed Healthcare divestiture does not close,
including failure to satisfy the closing conditions; risks related to the distraction of management from ongoing business operations and other opportunities due to the
proposed acquisitions and the proposed Healthcare divestiture; the effects of pending and future legislation and regulatory actions and reforms; macroeconomic and
industry trends and adverse developments in the debt, consumer credit and financial services markets and other macroeconomic factors beyond TransUnion’s control;
risks related to TransUnion’s indebtedness, including TransUnion’s ability to make timely payments of principal and interest and TransUnion’s ability to satisfy covenants in
the agreements governing its indebtedness; and other one-time events and other factors that can be found in TransUnion’s Annual Report on Form 10-K for the year ended
December 31, 2020, and any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K, which are filed with the Securities and Exchange Commission
and are available on TransUnion’s website (www.transunion.com/tru) and on the Securities and Exchange Commission’s website (www.sec.gov). TransUnion undertakes
no obligation to publicly release the result of any revisions to these forward-looking statements to reflect the impact of events or circumstances that may arise after the date
of this presentation.
Non-GAAP Financial Information
This investor presentation includes certain non-GAAP measures that are more fully described in our Current Report on Form 8-K, furnished as Exhibit 99.1, “Press release
of TransUnion dated October 26, 2021, announcing results for the quarter ended September 30, 2021” under the heading “Non-GAAP Financial Measures,” furnished to
the Securities and Exchange Commission on October 26, 2021. These financial measures should be reviewed in conjunction with the relevant GAAP financial measures
and are not presented as alternative measures of GAAP. Other companies in our industry may define or calculate these measures differently than we do, limiting their
usefulness as comparative measures. Because of these limitations, these non-GAAP financial measures should not be considered in isolation or as substitutes for
performance measures calculated in accordance with GAAP. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial
measures for each of the periods included in this presentation are included in the tables of Exhibit 99.1 of our Current Reports on Form 8-K furnished to the Securities and
Exchange Commission on October 26, 2021, July 27, 2021, April 27, 2021, February 16, 2021, October 27, 2020, July 28, 2020, April 28, 2020, February 18, 2020,
October 22, 2019, July 23, 2019 and April 23, 2019.

-- 2 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	3
Third quarter 2021 highlights	1
Fourth quarter and full year
2021 guidance
4
Strategic portfolio transformation	2
Third quarter 2021 financial results	3

-- 3 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	4
Third Quarter 2021 Highlights
• 	Delivered strong results that exceeded Q3 2021 guidance
• 	Benefited from continued market rebound with growth outpacing market
recovery
• 	Raised FY 2021 guidance based on strong Q3 and improved outlook
• 	Announced strategic acquisitions of Neustar and Sontiq, as well as minority
investments in Monevo and IDfy
• 	Agreed to divest our Healthcare business

-- 4 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	5
We are evolving to meet the
challenges of global digital
commerce, providing
identity verification 	and
targeting precision 	to
enable 	safe, tailored
consumer experiences

-- 5 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	6
Neustar Will Significantly Strengthen Our Identity
Resolution Capabilities
• 	Leverages best-in-class OneID platform to deliver real-time identity
resolution
• 	Bolsters our existing capabilities and increases scale and scope in
Marketing, Fraud and Communications
• 	Deepens pool of data science, engineering and sales talent
• 	Enhances already strong revenue growth with material revenue synergy
opportunities

-- 6 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	7
Neustar Underwent a Transformation Similar to
TransUnion
Right-Sized Portfolio
• 	Wound down NPAC contract
• 	Sold registry business
• 	Security business staying with
current private equity owner
Acquiring Neustar at
its growth inflection
and creating a leading
provider of real-time
identity resolution	Neustar 2017
take-private
Re-invigorated the
organization
• 	New leadership
• 	Bolstered go-to-market efforts
• 	Modern tech stack
• 	Redefined company culture
Turned OneID vision
into reality
• 	Best-in-class identity resolution
platform
• 	Backbone for Neustar
innovation
Today and Beyond

-- 7 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	8
• 	Sell Neustar products
into key verticals like
mid-market financial
services, insurance,
and public sector
• 	Benefit from Neustar’s
strength in areas like
communications, tech,
media and retail
Phase 1:
Cross-Sell
• 	Leverage combined
data sets
• 	Utilize OneID identity
resolution capabilities,
to create new
solutions in marketing
and fraud
Phase 2:
Innovation
• 	Roll-out OneID and
fraud and marketing
solutions in key
international markets
Phase 3:
Globalize
TransUnion + Neustar Will Generate Significant
Revenue Synergy Opportunities

-- 8 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	9
TransUnion + Neustar Creates a Powerhouse of
Future-Forward Marketing Solutions
• 	Scales our fast growing investment in marketing solutions
• 	Creates end-to-end capabilities around identity resolution, precision
targeting and marketing performance optimization
• 	Provides authoritative data with the technology and analytics to drive
actionable insights
• 	Delivers solutions to serve marketers in a highly regulated, post-cookie
world

-- 9 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	10
Sontiq Is a Leading Provider of Identity Protection
Solutions
• Founded in 2017 via combination of EZ Shield
and Identity Force and expanded in 2021 with
CyberScout and Breach Clarity acquisitions
• 	~150 employees; headquartered in
Nottingham, MD
• 	Serves a broad base of customers in employee
benefits, insurance, financial services and
public sector as well as its own direct-to-
consumer offering
• 	Purchase price of $638 million; expected to
close in the fourth quarter of 2021
~$60M
~$15M
~$10M
$85M revenue
(2021E)
Identity
Protection
Solutions
Check
Protection
Breach
Response

-- 10 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	11
Sontiq Will Position TransUnion as a Leader in
Identity Protection
• 	Expands position in large, fast growing ID Protection market
• 	Complements data-driven identity solutions while empowering consumers
to protect against identity and cyber threats
• 	Highly attractive financial profile
– 	$85 million 2021E revenue and expecting low-double-digit growth as part of TransUnion
– 	Attractive ~40% Adjusted EBITDA margins
– 	Neutral to 2022 Adjusted Diluted EPS; accretive thereafter

-- 11 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	12
Creating Best-in-Class Identity Verification and
Targeting Precision Capabilities
Purchase Price = $3.1 billion Minority Investments and
Strategic Partnerships
Purchase Price = $638 million
 	Leading provider of real-time
identity resolution,
underpinned by its best-in-
class OneID platform
 	Diversifies our portfolio,
scales our position in
Marketing and Fraud and
expands opportunities in
Communications
 	Identity protection platform
serving consumers and
businesses against identity
and cyber threats
 	Advances our Consumer
Interactive strategy to
provide consumers
comprehensive solutions via
direct and indirect channels
 	Monevo: Personal credit
platform enabling
aggregators and lenders to
pre-qualify consumers for
credit. Operates primarily in
U.K. and U.S.
 	IDfy: Indian-based provider
of video ID verification,
authentication and
onboarding solutions

-- 12 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	13
Divesting Healthcare to Sharpen Focus on Core
Markets and Capabilities
• 	Agreed to sell Healthcare for $1.735 billion and expected ~$1.4 billion after
tax1
• 	Generates proceeds that will fund significant portion of acquisitions of
Neustar and Sontiq
• 	Targeted to close in 4Q 2021, pending regulatory reviews
• 	Benefits from being part of larger healthcare data and analytics business
• 	Expected to generate ~$190 million of revenue at a mid-40% Adjusted EBITDA
margin in 2021E
1 At current tax rates.

-- 13 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	14
Consolidated
Q3 2021
Highlights
Year-over-Year
Change
Revenue 	14%
Constant Currency Revenue 	13%
Organic Constant Currency Revenue 	12%
Adjusted EBITDA 	21%
Constant Currency Adjusted EBITDA 	20%
Organic Constant Currency Adjusted EBITDA 	20%
Adjusted Diluted EPS 	24%
Note: For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.

-- 14 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	15
Note: Rows may not foot due to rounding. For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.
Reported 	FX Impact Inorganic
Impact
Organic Constant
Currency
Revenue 	14% 	— 	(1)% 	12%
Financial
Services 11% 	— 	— 	11%
Emerging
Verticals 17% 	— 	(3)% 	14%
Adjusted
EBITDA 19% 	— 	1% 	19%
U.S. Markets
Q3 2021
Year-over-Year
Financial
Highlights

-- 15 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	16
Consumer
Interactive
Q3 2021
Year-over-Year
Financial
Highlights
Reported 	FX Impact Inorganic
Impact
Organic Constant
Currency
Revenue 	3% 	— 	— 	3%
Adjusted
EBITDA 4% 	— 	— 	4%
Note: For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.

-- 16 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	17
Note: Rows may not foot due to rounding. For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.
International
Q3 2021
Year-over-Year
Financial
Highlights
Reported 	FX Impact Inorganic
Impact
Organic Constant
Currency
Revenue 	23% 	(5)% 	— 	18%
Canada 	10% 	(6)% 	— 	4%
Latin America 	23% 	(1)% 	— 	22%
U.K. 	24% 	(8)% 	— 	16%
Africa 	23% 	(15)% 	— 	8%
India 	44% 	(1)% 	— 	44%
Asia Pacific 	10% 	1% 	— 	11%
Adjusted
EBITDA 37% 	(6)% 	— 	31%

-- 17 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	18
TransUnion Has Shown a Consistent Ability to
De-lever via Adjusted EBITDA Growth
• 	Proven history of de-levering – first after 2015 IPO, and then following 2018 acquisitions
• 	Targeting < 3.5x net debt to Adjusted EBITDA by end of 2022
• 	$709 million of cash on balance sheet at quarter-end
2018 is pro-forma for acquisitions of Callcredit, iovation and HPS. Pro-forma 2021/22E includes Neustar and Sontiq
acquisitions as well as Healthcare divestiture.
Note: For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.
Net Debt / Adjusted EBITDA Ratio
4.8x
3.9x
3.4x 3.1x
4.5x 4.2x
3.2x 2.8x
2.0x
3.8x
3.3x
2015 IPO 	2015 	2016 	2017 	LTM 2Q18
(Acquisition
Financing)
2018 	2019 	2020 	2021E 	Pro-Forma
2021E
Pro-Forma
2022E

-- 18 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	19
Q4 2021 Guidance
Reported Revenue: $764M to $774M 	+9% to +11%
Assumed M&A contribution: 	No impact
Assumed FX contribution: 	Immaterial impact
Organic Constant Currency Revenue: 	+9% to +11%
Adjusted EBITDA: $293M to $301M 	+9% to +12%
Assumed FX contribution: 	Immaterial impact
Adjusted EBITDA Margin: 	-10bps to +40bps
Adjusted Diluted EPS: $0.88 to $0.91 	+10% to +14%
Q4 2021 revenue guidance includes
~4pt. mortgage headwind
Note: Guidance does not include announced acquisitions of Neustar and Sontiq nor divestiture of Healthcare.
For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.

-- 19 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	20
FY 2021 Guidance
Reported Revenue: $3.075B to $3.085B 	+13% to +14%
Assumed M&A contribution: 	~1pt. benefit
Assumed FX contribution: 	~1pt. benefit
Organic Constant Currency Revenue: 	~+12%
Assumed Mortgage impact: 	~2pt. headwind
Organic CC Revenue ex. Mortgage: 	~+14%
Adjusted EBITDA: $1.239B to $1.247B 	~+19%
Assumed FX contribution: 	~1pt. benefit
Adjusted EBITDA Margin: 	+180bps to +190bps
Adjusted Diluted EPS: $3.76 to $3.79 	+25% to +26%
• 	U.S. Markets up low-double-digits [up
high-teens ex. mortgage impact]
– 	Financial Services up low-double-digits [up
more than 20% ex. mortgage impact]
– 	Emerging Verticals up low-double-digits
• 	International up approximately 20% (as
reported)
• 	Consumer Interactive up mid-single-digits
Note: Guidance does not include announced acquisitions of Neustar and Sontiq nor divestiture of Healthcare.
For additional information, refer to the “Non-GAAP Financial Information” section on slide 2.

-- 20 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	21
• 	Delivered strong Q3 results and
increased FY 2021 guidance
• 	Acquiring Neustar and Sontiq to
diversify portfolio and
accelerate long-term growth
opportunities
• 	Announced divestiture of
Healthcare to sharpen strategic
focus while generating
significant proceeds

-- 21 of 22 --

© 2021 Trans Union LLC All Rights Reserved 	| 	22
Q&A

-- 22 of 22 --